http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20081891-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c076f2289bc2c7592e33f3c802d4912b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1682
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-438
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2008-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f431fe63ceb8bf2833dcabe31cdbc3ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eeaea9ce31c1b211ef2cec96d56eb1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57dfb220d9ae54c6876a09a7e0e80e38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f84bec3d20e6726e59a12557b8b8323
publicationDate 2008-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20081891-A1
titleOfInvention TABLET FORMULATIONS CONTAINING SALTS OF 8 - [{1- (3,5-BIS- (TRIFLUOROMETIL) PHENYL) -ETOXY} -METIL] -8-PHENYL-1,7-DIAZA-SPIRO [4.5] DECAN-2- ONA AND TABLETS MADE FROM THESE
abstract REFERS TO A PHARMACEUTICAL COMPOSITION IN TABLET FORM CONTAINING: A) A SALT (5S, 8S) -8 - [{(1R) -1- (3,5-BIS- (TRIFLUOROMETIL) PHENYL) -ETOXY } -METHYL] -8-PHENYL-1,7-DIAZASPIRO [4.5] DECAN-2-ONA, INTRAGRANULAR MICROCRYSTALLINE CELLULOSE, LACTOSE MONOHYDRATE, INTRAGRANULAR DISINTEGRANT SUCH AS CROSCARMEL SODIUM, BINDER SUCH AS POVIDIZON KEY, PREGOMED EYPATMINE 30 B) EXTRAGRANULAR MICROCRYSTALLINE CELLULOSE, EXTRAGRANULAR DISINTEGRANT SUCH AS SODIUM CROSCARMELOSUS, MAGNESIUM STEARATE. IT ALSO REFERS TO A PROCEDURE FOR THE PREPARATION OF THE COMPOSITION AND A METHOD OF TREATMENT OF EMESIS OR NAUSEA
priorityDate 2007-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177

Total number of triples: 33.